Novocure Announces Fourth Quarter and Full Year 2020 Preliminary Net Revenues and Provides Company Update
Novocure (NASDAQ: NVCR) today reported operating statistics and preliminary, unaudited net revenues and cash balances for the fourth quarter and full year 2020. Novocure plans to discuss these results with investors at the 39th Annual J.P. Morgan Virtual Healthcare Conference. Novocure also plans to highlight key clinical and product development programs.
| Fourth quarter and full year 2020 highlights include: | ||||||||||||||||||||||||||||||||||||||
| 
 | 
Three months ended
 | 
 | 
Twelve months ended
 | 
 | ||||||||||||||||||||||||||||||||||
| 
 | 
 | 2020 | 
 | 
 | 2019 | 
 | % Change | 
 | 
 | 2020 | 
 | 
 | 2019 | 
 | % Change | 
 | ||||||||||||||||||||||
| 
 | 
 | (unaudited) | 
 | 
 | (audited) | 
      Novocure
       NASDAQ:NVCRNVCR RankingsNVCR Latest NewsNVCR Latest SEC FilingsOct 30, 2025[10-Q] NovoCure Ltd Quarterly Earnings Report Oct 30, 2025[8-K] NovoCure Ltd Reports Material Event Sep 15, 2025[8-K] NovoCure Ltd Reports Material Event Aug 28, 2025[8-K] NovoCure Limited Reports Material Event NVCR Stock Data
         
        1.51B
       
         
        100.50M
       
         
        9.88%
       
         
        86.47%
       
         
        5.34%
       
         
        Medical Devices
       
        
        Surgical & Medical Instruments & Apparatus
       
        
        Switzerland
       
        
        ST. HELIER
       | ||||||||||||||||||||||||||||||||
 
             
             
             
             
             
             
             
             
         
         
         
        